For the third quarter of 2024, Ascendis Pharma reported a net loss of €99.2 million, or €1.72 per share (basic and diluted) ...

So, I’m sitting there watching a parade of commercials – interrupted from time to time by a football game – and I’m thinking … why do the beer and pharma companies spend so much on their little ...

Although incumbent Montana Sen. Jon Tester lost his race for U.S. Senate, that hasn’t stopped a barrage of attack ads running ...

Shares of Medicus Pharma tumbled 39%, to $2.50, on the company's first day of trading Thursday. The biotechnology and life-sciences pharmaceutical company on Wednesday said it would sell 970,000 units ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

BRS working president K T Rama Rao alleged that the police department is working like a private army of the Chief Minister to ...

It attributed the downturn to the July-August mass upsurge, labour unrest, and prolonged flooding, which significantly impacted operations and distribution channels.

Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...

The Wilmington International Airport and Frontier Scientific Solutions announced a new project utilizing the first free trade ...

The Inflation Reduction Act is unlikely to generate savings for taxpayers, while disrupting the market and creating perverse ...

On Wednesday, BridgeBio Pharma Inc (BBIO) stock saw a modest uptick, ending the day at $24.79 which represents a slight increase of $0.17 or 0.69% from the prior close of $24.62. The stock opened at ...